Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Locally Advanced or ROS1-Positive Non-Small Cell Lung Cancer (NSCLC). Show all posts
Showing posts with label Locally Advanced or ROS1-Positive Non-Small Cell Lung Cancer (NSCLC). Show all posts
Monday, August 12, 2024

FDA Approves Augtyro (repotrectinib) for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)

›
Bristol Myers Squibb (NYSE: BMY) announced  the U.S. Food and Drug Administration (FDA) approval of  Augtyro (repotrectinib) for the treatme...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.